Published

The Australia story: Current status and future challenges for the clinical applications of psychedelics.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: British journal of pharmacology
Date: 2026-07-01
Source: PubMed
DOI: 10.1111/bph.17398
PubMed: 39701143

Authors

Nutt DJ Hunt P Schlag AK Fitzgerald P

Watch author

Derived topics and classifications

psilocybin Depression PTSD Mechanism of Action Review Article Treatment-Resistant Depression Review Article

Citation graph

0 referenced DOIs found in stored source metadata. 4 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholders2026-07-01 The Australia story: Current status and future challenges for the clinical applications of psychedelics.2026-07-01 Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations2026-06-01 Psychedelics in NHS services: exploring a model for real-world implementation of psilocybin2026-03-30

Related papers

Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility.Frontiers in neuroscience · 2026-01-01 Psychedelics and mental health: reimagining care through science, insight, and compassion.Frontiers in pharmacology · 2025-01-01 Investigation of Psychedelic Effects in Psychoactive SubstancesClinicalTrials.gov · 2026-02-23 Psilocybin and MDMA for Post-traumatic Stress Disorder (PTSD)ClinicalTrials.gov · 2025-10-01 The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy TrainingClinicalTrials.gov · 2025-04-14